Literature DB >> 17021277

Estimating and modeling the cure fraction in population-based cancer survival analysis.

Paul C Lambert1, John R Thompson, Claire L Weston, Paul W Dickman.   

Abstract

In population-based cancer studies, cure is said to occur when the mortality (hazard) rate in the diseased group of individuals returns to the same level as that expected in the general population. The cure fraction (the proportion of patients cured of disease) is of interest to patients and is a useful measure to monitor trends in survival of curable disease. There are 2 main types of cure fraction model, the mixture cure fraction model and the non-mixture cure fraction model, with most previous work concentrating on the mixture cure fraction model. In this paper, we extend the parametric non-mixture cure fraction model to incorporate background mortality, thus providing estimates of the cure fraction in population-based cancer studies. We compare the estimates of relative survival and the cure fraction between the 2 types of model and also investigate the importance of modeling the ancillary parameters in the selected parametric distribution for both types of model.

Entities:  

Mesh:

Year:  2006        PMID: 17021277     DOI: 10.1093/biostatistics/kxl030

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  42 in total

1.  Spontaneous Clearance of the Hepatitis C Virus Among Men Who Have Sex With Men.

Authors:  Eric C Seaberg; Mallory D Witt; Lisa P Jacobson; Roger Detels; Charles R Rinaldo; Joseph B Margolick; Stephen Young; John P Phair; Chloe L Thio
Journal:  Clin Infect Dis       Date:  2015-07-14       Impact factor: 9.079

2.  Using Evidence from Randomised Controlled Trials in Economic Models: What Information is Relevant and is There a Minimum Amount of Sample Data Required to Make Decisions?

Authors:  John W Stevens
Journal:  Pharmacoeconomics       Date:  2018-10       Impact factor: 4.981

3.  Assessing the fit of parametric cure models.

Authors:  E Paul Wileyto; Yimei Li; Jinbo Chen; Daniel F Heitjan
Journal:  Biostatistics       Date:  2012-11-28       Impact factor: 5.899

4.  Cure trends in acute lymphoblastic leukemia: is it time for a revised concept of cure?

Authors:  Christian Michel Zwaan; Richard Sposto
Journal:  Haematologica       Date:  2013-05       Impact factor: 9.941

5.  Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.

Authors:  Susan L Tucker; Lei Dong; Walter R Bosch; Jeff Michalski; Kathryn Winter; Radhe Mohan; James A Purdy; Deborah Kuban; Andrew K Lee; M Rex Cheung; Howard D Thames; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-02       Impact factor: 7.038

6.  A Case Study Examining the Usefulness of Cure Modelling for the Prediction of Survival Based on Data Maturity.

Authors:  Tim S Grant; Darren Burns; Christopher Kiff; Dawn Lee
Journal:  Pharmacoeconomics       Date:  2020-04       Impact factor: 4.981

7.  Bias in Mean Survival From Fitting Cure Models With Limited Follow-Up.

Authors:  Megan Othus; Aasthaa Bansal; Harry Erba; Scott Ramsey
Journal:  Value Health       Date:  2020-07-31       Impact factor: 5.725

8.  A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience.

Authors:  Claudio Ricci; Davide Campana; Chiara Casadei; Carlo Ingaldi; Valentina Ambrosini; Nico Pagano; Donatella Santini; Cristina Mosconi; Nicole Brighi; Laura Alberici; Francesco Minni; Riccardo Casadei
Journal:  Endocrine       Date:  2019-02-22       Impact factor: 3.633

9.  Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer.

Authors:  Margaret R Stedman; Eric J Feuer; Angela B Mariotto
Journal:  J Natl Cancer Inst Monogr       Date:  2014-11

10.  Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer.

Authors:  Gaya Spolverato; Fabio Bagante; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Emily Winslow; Clifford Cho; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.